Cargando…
The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells
PURPOSE: Photodynamic therapy (PDT), sonodynamic therapy (SDT), and oxaliplatin (OXP) can induce immunogenic cell death (ICD) following damage-associated molecular patterns (DAMPs) exposure or release and can be united via the use of nanoplatforms to deliver drugs that can impart anti-tumor effects....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896924/ https://www.ncbi.nlm.nih.gov/pubmed/31819438 http://dx.doi.org/10.2147/IJN.S208404 |
_version_ | 1783476881075470336 |
---|---|
author | Xie, Wan Zhu, Shenyin Yang, Biyong Chen, Chunyan Chen, Shuning Liu, Yujiao Nie, Xuyuan Hao, Lan Wang, Zhigang Sun, Jiangchuan Chang, Shufang |
author_facet | Xie, Wan Zhu, Shenyin Yang, Biyong Chen, Chunyan Chen, Shuning Liu, Yujiao Nie, Xuyuan Hao, Lan Wang, Zhigang Sun, Jiangchuan Chang, Shufang |
author_sort | Xie, Wan |
collection | PubMed |
description | PURPOSE: Photodynamic therapy (PDT), sonodynamic therapy (SDT), and oxaliplatin (OXP) can induce immunogenic cell death (ICD) following damage-associated molecular patterns (DAMPs) exposure or release and can be united via the use of nanoplatforms to deliver drugs that can impart anti-tumor effects. The aim of this study was to develop phase-transition nanoparticles (OI_NPs) loaded with perfluoropentane (PFP), indocyanine green (ICG), and oxaliplatin (OXP), to augment anti-tumor efficacy and the immunological effects of chemotherapy, photodynamic therapy and sonodynamic therapy (PSDT). METHODS: OI_NPs were fabricated by a double emulsion method and a range of physicochemical and dual-modal imaging features were characterized. Confocal microscopy and flow cytometry were used to determine the cellular uptake of OI_NPs by ID8 cells. The viability and apoptotic rate of ID8 cells were investigated using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay and flow cytometry. Flow cytometry, Western blotting, and luminometric assays were then used to investigate the exposure or release of crucial DAMPs such as calreticulin (CRT), high mobility group box 1 (HMGB1), and adenosine-5ʹ-triphosphate (ATP). Tumor rechallenge experiments were then used to investigate whether treated ID8 cells underwent ICD. Finally, cytotoxic T lymphocyte (CTL) activity was determined by a lactate dehydrogenase (LDH) assay. RESULTS: Spherical OI_NPs were able to carry OXP, ICG and PFP and were successfully internalized by ID8 cells. The application of OI_NPs significantly enhanced the phase shift ability of PFP and the optical characteristics of ICG, thus leading to a significant improvement in photoacoustic and ultrasonic imaging. When combined with near-infrared light and ultrasound, the application of OI_NPs led to improved anti-tumor effects on cancer cells, and significantly enhanced the expression of DAMPs, thus generating a long-term anti-tumor effect. CONCLUSION: The application of OI_NPs, loaded with appropriate cargo, may represent a novel strategy with which to increase anti-tumor effects, enhance immunological potency, and improve dual-mode imaging. |
format | Online Article Text |
id | pubmed-6896924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-68969242019-12-09 The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells Xie, Wan Zhu, Shenyin Yang, Biyong Chen, Chunyan Chen, Shuning Liu, Yujiao Nie, Xuyuan Hao, Lan Wang, Zhigang Sun, Jiangchuan Chang, Shufang Int J Nanomedicine Original Research PURPOSE: Photodynamic therapy (PDT), sonodynamic therapy (SDT), and oxaliplatin (OXP) can induce immunogenic cell death (ICD) following damage-associated molecular patterns (DAMPs) exposure or release and can be united via the use of nanoplatforms to deliver drugs that can impart anti-tumor effects. The aim of this study was to develop phase-transition nanoparticles (OI_NPs) loaded with perfluoropentane (PFP), indocyanine green (ICG), and oxaliplatin (OXP), to augment anti-tumor efficacy and the immunological effects of chemotherapy, photodynamic therapy and sonodynamic therapy (PSDT). METHODS: OI_NPs were fabricated by a double emulsion method and a range of physicochemical and dual-modal imaging features were characterized. Confocal microscopy and flow cytometry were used to determine the cellular uptake of OI_NPs by ID8 cells. The viability and apoptotic rate of ID8 cells were investigated using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay and flow cytometry. Flow cytometry, Western blotting, and luminometric assays were then used to investigate the exposure or release of crucial DAMPs such as calreticulin (CRT), high mobility group box 1 (HMGB1), and adenosine-5ʹ-triphosphate (ATP). Tumor rechallenge experiments were then used to investigate whether treated ID8 cells underwent ICD. Finally, cytotoxic T lymphocyte (CTL) activity was determined by a lactate dehydrogenase (LDH) assay. RESULTS: Spherical OI_NPs were able to carry OXP, ICG and PFP and were successfully internalized by ID8 cells. The application of OI_NPs significantly enhanced the phase shift ability of PFP and the optical characteristics of ICG, thus leading to a significant improvement in photoacoustic and ultrasonic imaging. When combined with near-infrared light and ultrasound, the application of OI_NPs led to improved anti-tumor effects on cancer cells, and significantly enhanced the expression of DAMPs, thus generating a long-term anti-tumor effect. CONCLUSION: The application of OI_NPs, loaded with appropriate cargo, may represent a novel strategy with which to increase anti-tumor effects, enhance immunological potency, and improve dual-mode imaging. Dove 2019-12-02 /pmc/articles/PMC6896924/ /pubmed/31819438 http://dx.doi.org/10.2147/IJN.S208404 Text en © 2019 Xie et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Xie, Wan Zhu, Shenyin Yang, Biyong Chen, Chunyan Chen, Shuning Liu, Yujiao Nie, Xuyuan Hao, Lan Wang, Zhigang Sun, Jiangchuan Chang, Shufang The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells |
title | The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells |
title_full | The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells |
title_fullStr | The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells |
title_full_unstemmed | The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells |
title_short | The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells |
title_sort | destruction of laser-induced phase-transition nanoparticles triggered by low-intensity ultrasound: an innovative modality to enhance the immunological treatment of ovarian cancer cells |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896924/ https://www.ncbi.nlm.nih.gov/pubmed/31819438 http://dx.doi.org/10.2147/IJN.S208404 |
work_keys_str_mv | AT xiewan thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT zhushenyin thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT yangbiyong thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT chenchunyan thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT chenshuning thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT liuyujiao thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT niexuyuan thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT haolan thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT wangzhigang thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT sunjiangchuan thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT changshufang thedestructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT xiewan destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT zhushenyin destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT yangbiyong destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT chenchunyan destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT chenshuning destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT liuyujiao destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT niexuyuan destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT haolan destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT wangzhigang destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT sunjiangchuan destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells AT changshufang destructionoflaserinducedphasetransitionnanoparticlestriggeredbylowintensityultrasoundaninnovativemodalitytoenhancetheimmunologicaltreatmentofovariancancercells |